Patent classifications
A61K2236/15
WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS
The invention provides therapeutic compositions containing willow extract, such as willow leaf extract, methods of medical treatment using such compositions, and methods for preparing such compositions.
Method for preparing health foods comprising aloeswood having effects of preventing absorption of heavy metals into body and excreting the same from body
A method for preparing health foods having aloeswood. Preparing materials in which aloeswood, Saururus chinensis, Huperzia, white tea and Houttuynia cordata Thunb are each washed, and then dried in shade, pulverized and roasted. The roasted aloeswood, Saururus chinensis, Huperzia, white tea and Houttuynia cordata Thunb are mixed at a weight ratio of 4:1:1:1:1. The brewed and distilled aloeswood, Saururus chinensis and water mixture is mixed with the maturing an aloeswood, Saururus chinensis, Huperzia, white tea and Houttuynia cordata Thunb mixture and double boiled to prepare a leachate. The prepared leachate is extracted and concentrated, and then heat-matured to remove the moisture. The heat-matured extract is cool-dried, mixed with mineral water, then heated, dried at room temperature and molded into a predetermined shape. The prepared health foods having effects in preventing absorption of heavy metals in body and excreting the same from body.
Method of extracting active ingredients in mushrooms
A method of extracting active ingredients in mushrooms includes following steps: crushing a mushroom to obtain a crude mushroom crush; mixing the crude mushroom crush with deionized water to obtain a crude crush mixture; adding the crude crush mixture into a subcritical fluid extractor and extracting the crude crush mixture to obtain a crude mushroom extract; centrifuging the crude mushroom extract to harvest a first supernatant and a mushroom residue; mixing the mushroom residue with deionized water and a cellulase enzyme to obtain a reaction mixture; adding the reaction mixture into a high-pressure hydrolysis reactor and extracting the reaction mixture to obtain a hydrolysate; centrifuging the hydrolysate to obtain a second supernatant; and combining the first supernatant and the second supernatant, and then concentrating the combined first and second supernatants to obtain a mushroom extraction solution.
BOTANICAL ANTIVIRAL NUTRITIONAL SUPPLEMENT
A botanical antiviral nutritional supplement includes ground Achillea Millefolium, ground Bryophyllum Pinnatum, ground Sambucus Nigra, ground Neurolaena Lobata, ground Verbascum Thapsus, ground Morinda Citrifolia, ground Prunella Vulgaris, and ground Salvia Officinalis. A method of producing the antiviral nutritional supplement includes drying the botanical ingredients; grinding the dried ingredients; and blending the ground, dried ingredients. The supplement is believed to improve the health of a person infected with a virus and to relieve brain fog.
COMPOSITIONS DERIVED FROM SALVIA HISPANICA SEEDS
Methods of preparing a composition from chia seeds are provided. Compositions, including compositions prepared by the presently disclosed methods, and methods regarding selecting chia seeds and administering chia seed extracts are also disclosed.
Production and use of the leaf and/or leaves and/or stem(s) and/or stalk(s) of plants of the cannabis species for consumption as a food, beverage ingredient, supplement, medicine
This present invention is directed to a method for the production and use of the leaf and/or leaves and/or stem(s) and/or stalk(s) of plants of the cannabis species for animal, microbial, bacteria, fungi or human consumption as a food, supplement, medicine, beverage.
VEGETABLE POWDERS, METHODS FOR MANUFACTURING VEGETABLE POWDERS, AND KITS THEREOF
Methods of manufacturing vegetable powders and/or vegetable compositions are described herein.
Process to enhance the bioactivity of Ashwagandha extracts
The invention relates to an extract of Ashwagandha that exhibit enhanced bioactivity and bioavailability comprising of enriched withanolide glycosides and saponins; with negligible amount of alkaloids, withanolide aglycones and oligosaccharides. The extract as disclosed prepared from root, stems, leaves and whole plant of Ashwagandha further shows improved immunomodulatory activity, anti-inflammatory activity, anti stress activity, antidiabetic activity and sleep quality. The disclosure also provides a method of improving bioactivity of withanolide glycosides even at lower doses, by the administration of an enteric coated formulation of extract of Ashwagandha to humans. The enteric coating protects the composition from hydrolysis in the acidic environment of the stomach to release the withanolide glycoside in neutral/alkaline pH in gastrointestinal tract (GIT) thus enhancing the absorption. Further the process of preparation of the extract of Ashwagandha enriched with withanolide glycosides and saponins are disclosed along with various formulations.
MODULATION OF NCRNAS, LYMPHOCYTES, NEUTROPHILS, INFLAMMASOMES AND P53
Composition for modulation/regulation ncRNAs, Lymphocytes, Neutrophils, Inflammasomes and p53 for prevention, treatment and management of immune dysregulation, inflammation dysregulation and energy dysregulation, caused by respiratory viruses (COVID19, Influenza etc), or leading to Acute Respiratory Distress Syndrome (ARDS), Sepsis and Long Covid, immune senescence.
Method for preparing additive-free cell-wall-broken granule of Chinese medicinal material
The present invention provides a method for preparing an additive-free cell-wall-broken granule of a Chinese medicinal material. The cell-wall-broken granule is obtained by medicinal material concocting and grinding, first cell-wall-breaking and grinding, screening, second wall-breaking and grinding, mixing, pelleting, and granulating and sieving. The obtained granule has a moderate tightness, a relatively rapid dissolution and diffusion and a good uniformity, overcoming problems of a difficulty of dissolution and diffusion and a poor uniformity of the existing cell-wall-broken granules.